Metastatic breast cancer: preliminary results with oral hormonal therapy.

Joseph C. Allegra, Lawrence Einhorn(University of Louisville Hospital), Henry J. Durivage(Soligenix (United States)), Philip Bonomi(Rush University Medical Center), P. Byrne(University of Louisville Hospital), Bruce W. Dana(Unknown), John T. Carpenter(University of Louisville Hospital), Joseph Bertino(Yale University), Robert B. Catalano, R H Creech(University of Louisville Hospital)
PubMed
December 1, 1985
Cited by 17

Related Papers

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
|Journal of Clinical Oncology|2004|1.1k
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
|Journal of Clinical Oncology|1991|383
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
|Journal of Clinical Oncology|1993|193
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial
|Clinical Cancer Research|2016|126
Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series
|Cancer|1986|123